Serotonin and dopamine receptors in motivational and cognitive disturbances of schizophrenia

Frontiers in Neuroscience

Volumn 8, Issue DEC, 2014, Pages

  Sumiyoshi, Tomiki ^a   Kunugi, Hiroshi ^b   Nakagome, Kazuyuki ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

5 HT receptors; Cognition; Dopamine; Motivation; Negative symptoms; Psychosis; Schizophrenia; Serotonin

Indexed keywords

4 AMINOBUTYRIC ACID; CATECHOL METHYLTRANSFERASE; DOPAMINE RECEPTOR; SEROTONIN 1 RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 2D RECEPTOR; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; COGNITION; CORPUS STRIATUM; EXECUTIVE FUNCTION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MONOAMINERGIC SYSTEM; MOTIVATION; NEGATIVE SYNDROME; NUCLEUS ACCUMBENS; REWARD; SCHIZOPHRENIA; UPREGULATION; VENTRAL TEGMENTUM; WORKING MEMORY;

EID: 84920559964     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2014.00395     Document Type: Article

References (27)

1. Akubuiro, A., Bridget Zimmerman, M., Boles Ponto, L. L., Walsh, S. A., Sunderland, J., McCormick, L., et al. (2013). Hyperactive hypothalamus, motivated and non-distractible chronic overeating in ADAR2 transgenic mice. Genes Brain Behav. 12, 311-322. doi: 10.1111/gbb.12020
2. Bubar, M. J., Stutz, S. J., and Cunningham, K. A. (2011). 5-HT(2C) receptors localize to dopamine and GABA neurons in the rat mesoaccumbens pathway. PLoS ONE 6:e20508. doi: 10.1371/journal.pone.0020508
3. Choi, J., Choi, K. H., Felice Reddy, L., and Fiszdon, J. M. (2014). Measuring motivation in schizophrenia: is a general state of motivation necessary for task-specific motivation? Schizophr. Res. 153, 209-213. doi: 10.1016/j.schres.2014.01.027
4. Del'Guidice, T., Lemay, F., Lemasson, M., Levasseur-Moreau, J., Manta, S., Etievant, A., et al. (2014). Stimulation of 5-HT2C receptors improves cognitive deficits induced by human tryptophan hydroxylase 2 loss of function mutation. Neuropsychopharmacology 39, 1125-1134. doi: 10.1038/npp.2013.313
5. Drew, M. R., Simpson, E. H., Kellendonk, C., Herzberg, W. G., Lipatova, O., Fairhurst, S., et al. (2007). Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing. J. Neurosci. 27, 7731-7739. doi: 10.1523/JNEUROSCI.1736-07.2007
6. Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., et al. (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 98, 6917-6922. doi: 10.1073/pnas.111134598
7. Fervaha, G., Agid, O., Foussias, G., and Remington, G. (2014). Effect of intrinsic motivation on cognitive performance in schizophrenia: a pilot study. Schizophr. Res. 152, 317-318. doi: 10.1016/j.schres.2013.11.037
8. Frank, M. J., Doll, B. B., Oas-Terpstra, J., and Moreno, F. (2009). Prefrontal and striatal dopaminergic genes predict individual differences in exploration and exploitation. Nat. Neurosci. 12, 1062-1068. doi: 10.1038/nn.2342
9. Frank, M. J., Moustafa, A. A., Haughey, H. M., Curran, T., and Hutchison, K. E. (2007). Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning. Proc. Natl. Acad. Sci. U.S.A. 104, 16311-16316. doi: 10.1073/pnas.0706111104
10. Harvey, P. D., Raykov, T., Twamley, E. W., Vella, L., Heaton, R. K., and Patterson, T. L. (2011). Validating the measurement of real-world functional outcomes: phase I results of the VALERO study. Am. J. Psychiatry 168, 1195-1201. doi: 10.1176/appi.ajp.2011.10121723
11. Hirvonen, M., Laakso, A., Nagren, K., Rinne, J. O., Pohjalainen, T., and Hietala, J. (2004). C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol. Psychiatry 9, 1060-1061. doi: 10.1038/sj.mp.4001561
12. Kellendonk, C., Simpson, E. H., Polan, H. J., Malleret, G., Vronskaya, S., Winger, V., et al. (2006). Transient and selective overexpression of D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 16, 603-615. doi: 10.1016/j.neuron.2006.01.023
13. Klein, T. A., Neumann, J., Reuter, M., Hennig, J., Von Cramon, D. Y., and Ullsperger, M. (2007). Genetically determined differences in learning from errors. Science 318, 1642-1645. doi: 10.1126/science.1145044
14. Leifker, F. R., Patterson, T. L., Heaton, R. K., and Harvey, P. D. (2011). Validating measures of real-world outcome: the results of the VALERO expert survey and RAND panel. Schizophr. Bull. 37, 334-343. doi: 10.1093/schbul/sbp044
15. Meltzer, H. Y., and Massey, B. W. (2011). The role of serotonin receptors in the action of atypical antipsychotic drugs. Curr. Opin. Pharmacol. 11, 59-67. doi: 10.1016/j.coph.2011.02.007
16. Murayama, K., Matsumoto, M., Izuma, K., and Matsumoto, K. (2010). Neural basis of the undermining effect of monetary reward on intrinsic motivation. Proc. Natl. Acad. Sci. U.S.A. 107, 20911-20916. doi: 10.1073/pnas.1013305107
17. Newman-Tancredi, A., and Albert, P. R. (2012). "Gene polymorphism at serotonin 5-HT1A receptors: moving towards personalized medicine for psychosis and mood deficits?," in Schizophrenia Research: Recent Advances, ed T. Sumiyoshi (New York, NY: Nova Science Publishers), 337-358.
18. Ohno, Y., Tatara, A., Shimizu, S., and Sasa, M. (2012). "Management of cognitive impairments in schizophrenia: the therapeutic role of 5-HT receptors," in Schizophrenia Research: Recent Advances, ed T. Sumiyoshi (New York, NY: Nova Science Publishers), 321-335.
19. Reynolds, G. P., Arranz, B., Templeman, L. A., Fertuzinhos, S., and San, L. (2006). Effect of 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naive psychotic patients. Am. J. Psychiatry 163, 1826-1829. doi: 10.1176/appi.ajp.163.10.1826
20. Schlosser, D. A., Fisher, M., Gard, D., Fulford, D., Loewy, R. L., and Vinogradov, S. (2014). Motivational deficits in individuals at-risk for psychosis and across the course of schizophrenia. Schizophr. Res. 158, 52-57. doi: 10.1016/j.schres.2014.06.024
21. Simpson, E. H., Kellendonk, C., Ward, R. D., Richards, V., Lipatova, O., Fairhurst, S., et al. (2011). Pharmacologic rescue of motivational deficit in an animal model of the negative symptoms of schizophrenia. Biol. Psychiatry 69, 928-935. doi: 10.1016/j.biopsych.2011.01.012
22. Simpson, E. H., Winiger, V., Biezonski, D. K., Haq, I., Kandel, E. R., and Kellendonk, C. (2013). Selective overexpression of dopamine d3 receptors in the striatum disrupts motivation but not cognition. Biol. Psychiatry 76, 823-831. doi: 10.1016/j.biopsych.2013.11.023
23. Strauss, G. P., Waltz, J. A., and Gold, J. M. (2014). A review of reward processing and motivational impairment in schizophrenia. Schizophr. Bull. 40(Suppl. 2), S107-S116. doi: 10.1093/schbul/sbt197
24. Sumiyoshi, T. (in press). "Cognitive impairment in schizophrenia," in Encyclopedia of Psychopharmacology, 2nd Edn., eds I. Stolerman and L. H. Price (New York, NY: Springer), 1-7.
25. Sumiyoshi, T. (2014). Serotonin(1A) receptors in the action of aripiprazole. J. Clin. Psychopharmacol. 34, 396-397. doi: 10.1097/JCP.0000000000000135
26. Sumiyoshi, T., Higuchi, Y., and Uehara, T. (2013). Neural basis for the ability of atypical antipsychotic drugs to improve cognition in schizophrenia. Front. Behav. Neurosci. 7:140. doi: 10.3389/fnbeh.2013.00140
27. Ward, R. D., Kellendonk, C., Simpson, E. H., Lipatova, O., Drew, M. R., Fairhurst, S., et al. (2009). Impaired timing precision produced by striatal D2 receptor overexpression is mediated by cognitive and motivational deficits. Behav. Neurosci. 123, 720-730. doi: 10.1037/a0016503